BioSpace News Archive

BioCapital

AUA Announces Update to its Overactive Bladder Clinical Practice Guideline

This amendment is the product of the AUA’s literature review process, whereby an additional systematic review is conducted to maintain guideline currency with newly published and relevant literature.

April 25, 2019
·
2 min read
Drug Development

ACADIA Pharmaceuticals Initiates Phase 3 CLARITY Program with Pimavanserin as Adjunctive Treatment for Major Depressive Disorder

Pimavanserin is a selective serotonin inverse agonist preferentially targeting 5-HT2A receptors, which may play a role in depression.

April 25, 2019
·
9 min read
Pharm Country

Oyster Point Pharma to Present at the 2019 ASCRS•ASOA Annual Meeting and at the Ophthalmology Innovation Summit (OIS) Meeting

Oyster Point Pharma, Inc. announced multiple data presentations of the company’s product candidates at the 2019 American Society for Cataract and Refractive Surgery Annual Meeting and at the Ophthalmology Innovation Summit meeting, taking place May 2-7 in San Diego.

April 25, 2019
·
2 min read
JPND Launches Updated Research and Innovation Strategy - April 25, 2019

The EU Joint Programme – Neurodegenerative Disease Research initiative1 has launched its updated global Research and Innovation Strategy, to provide a unified framework for the support of world class research into neurodegenerative diseases.

April 25, 2019
·
5 min read
Business

Crescita Therapeutics Signs Pliaglis Out-Licensing Agreement with Cantabria Labs for $2.5M Upfront After Reacquiring Rest-of-World Rights

Cantabria Labs is a leading prescription dermatology company in Europe with a presence in over 80 countries.

April 25, 2019
·
7 min read
Biotech Beach

Eyenuk Will Announce Results From Prospective, Multi-Center, Pivotal Clinical Trial on the EyeArt® AI Eye Screening System at ARVO Conference

Artificial Intelligence (AI) Technology Developed To Make In-Clinic, Real-Time Diabetic Retinopathy Screening Possible for Any Physician

April 25, 2019
·
3 min read
Business

The Cardinal Health Foundation and Kroger Co-host Nationwide Drug Take-Back Events on April 27

The Cardinal Health Foundation and Kroger will host drug take-back events at more than 200 local pharmacy locations across the country from 10 a.m. – 2 p.m. on Saturday, April 27, 2019 as part of the U.S. Drug Enforcement Administration’s National Prescription Drug Take-Back Day.

April 25, 2019
·
4 min read
BioCapital

BPSA Awards Training and Education Grants to 3 University-Based Centers for Bio-Processing Skills Enhancements

Honored recipients are North Carolina State, Texas A&M, Worcester Polytechnic Institute

April 25, 2019
·
1 min read
BioCapital

IBBR investigator to lead $3.5M NIH-funded project to study immune response to HIV-1

Funding will support novel vaccine design aimed at improving protective antibody responses

April 25, 2019
·
3 min read
Leading Independent Proxy Advisory Firm ISS Recommends Change at Knight Therapeutics

ISS Notes “Stark” Underperformance, Recommends Election of New Independent Directors and for Knight Shareholders to Vote on the GOLD Proxy Card

April 25, 2019
·
9 min read